India's Commerce Ministry says it is soon to lift import restrictions onpenicillin, rifampicin and 6-APA, by removing them from the negative list of imports.
Industry sources say this will force major domestic producers of these intermediates, including Torrent, Gujart Biotech, JK Pharmachem, Hindustan Max GB and Lupin Chemicals, to reduce their products' prices, reports the Marketletter's New Delhi correspondent.
The sources also note that the Ministry has recently told the Department of Chemicals and Petrochemicals that import restrictions on the three intermediates are no longer tenable under Article 20 of the General Agreement on Tariffs and Trade.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze